CVRx IncNASDAQ:CVRX
- LAST PRICE6.9500
- TODAY'S CHANGE (%)0.0700 (1.0174%)
- Bid / Lots6.7500/ 1
- Ask / Lots7.7700/ 1
- Open / Previous Close6.8500 / 6.8800
- Day Range
- 52 Week Range
- Volume337,975
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CVRX |
|---|---|---|
| 09:32 ET | 2042 | 6.805 |
| 09:38 ET | 100 | 6.82 |
| 09:43 ET | 1616 | 6.915 |
| 09:45 ET | 2400 | 6.91 |
| 09:48 ET | 13401 | 6.945 |
| 09:50 ET | 900 | 6.91 |
| 09:52 ET | 225 | 6.95 |
| 09:56 ET | 606 | 6.88 |
| 09:57 ET | 200 | 6.86 |
| 09:59 ET | 100 | 6.895 |
| 10:01 ET | 100 | 6.86 |
| 10:12 ET | 100 | 6.86 |
| 10:14 ET | 1469 | 6.865 |
| 10:15 ET | 100 | 6.83 |
| 10:17 ET | 100 | 6.865 |
| 10:19 ET | 3300 | 6.875 |
| 10:21 ET | 2357 | 6.91 |
| 10:24 ET | 9374 | 6.93 |
| 10:26 ET | 1519 | 6.92 |
| 10:28 ET | 2423 | 6.96 |
| 10:32 ET | 14548 | 6.95 |
| 10:33 ET | 5900 | 7.02 |
| 10:37 ET | 100 | 7 |
| 10:42 ET | 100 | 7.02 |
| 10:44 ET | 200 | 7.02 |
| 10:46 ET | 4445 | 7.05 |
| 10:48 ET | 2348 | 7.07 |
| 10:50 ET | 800 | 7.07 |
| 10:51 ET | 500 | 7.07 |
| 10:53 ET | 600 | 7.115 |
| 10:57 ET | 300 | 7.1297 |
| 11:00 ET | 1203 | 7.1 |
| 11:04 ET | 1104 | 7.09 |
| 11:08 ET | 100 | 7.15 |
| 11:11 ET | 8481 | 7.17 |
| 11:13 ET | 1200 | 7.12 |
| 11:15 ET | 6900 | 7.13 |
| 11:18 ET | 8350 | 7.1889 |
| 11:20 ET | 844 | 7.2 |
| 11:22 ET | 158 | 7.23 |
| 11:24 ET | 600 | 7.24 |
| 11:26 ET | 1223 | 7.22 |
| 11:29 ET | 100 | 7.2 |
| 11:31 ET | 800 | 7.2 |
| 11:36 ET | 100 | 7.2 |
| 11:38 ET | 200 | 7.19 |
| 11:42 ET | 929 | 7.13 |
| 11:44 ET | 600 | 7.11 |
| 11:47 ET | 500 | 7.07 |
| 12:00 ET | 484 | 7.03 |
| 12:09 ET | 2700 | 7.02 |
| 12:12 ET | 2426 | 7.04 |
| 12:14 ET | 553 | 7.04 |
| 12:16 ET | 200 | 7.03 |
| 12:18 ET | 390 | 7.03 |
| 12:20 ET | 2504 | 7.06 |
| 12:21 ET | 800 | 7.05 |
| 12:23 ET | 5073 | 7.06 |
| 12:34 ET | 300 | 7.06 |
| 12:36 ET | 1144 | 7.07 |
| 12:38 ET | 200 | 7.05 |
| 12:39 ET | 100 | 7.05 |
| 12:41 ET | 100 | 7.08 |
| 12:43 ET | 300 | 7.0701 |
| 12:48 ET | 501 | 7.07 |
| 12:52 ET | 1404 | 7.05 |
| 12:54 ET | 100 | 7.06 |
| 01:01 ET | 3707 | 7.02 |
| 01:08 ET | 2838 | 7.01 |
| 01:10 ET | 100 | 6.99 |
| 01:12 ET | 1200 | 6.98 |
| 01:14 ET | 100 | 6.98 |
| 01:15 ET | 100 | 6.98 |
| 01:17 ET | 200 | 6.98 |
| 01:19 ET | 100 | 6.98 |
| 01:28 ET | 2971 | 6.97 |
| 01:30 ET | 100 | 6.975 |
| 01:32 ET | 300 | 6.975 |
| 01:33 ET | 732 | 6.975 |
| 01:44 ET | 181 | 6.9702 |
| 01:46 ET | 831 | 6.99 |
| 01:48 ET | 2486 | 6.96 |
| 01:57 ET | 3809 | 6.95 |
| 02:02 ET | 300 | 6.97 |
| 02:06 ET | 500 | 6.965 |
| 02:08 ET | 100 | 6.96 |
| 02:11 ET | 200 | 6.95 |
| 02:13 ET | 1702 | 6.97 |
| 02:15 ET | 3275 | 7.01 |
| 02:18 ET | 200 | 7.03 |
| 02:20 ET | 826 | 7.05 |
| 02:22 ET | 100 | 7.04 |
| 02:24 ET | 300 | 7.04 |
| 02:26 ET | 500 | 7.04 |
| 02:27 ET | 160 | 7.05 |
| 02:31 ET | 900 | 7.01 |
| 02:38 ET | 912 | 6.98 |
| 02:40 ET | 1454 | 6.97 |
| 02:44 ET | 3600 | 7.01 |
| 02:49 ET | 1336 | 6.99 |
| 02:54 ET | 428 | 6.95 |
| 02:56 ET | 100 | 6.95 |
| 02:58 ET | 400 | 6.965 |
| 03:02 ET | 600 | 6.95 |
| 03:03 ET | 249 | 6.95 |
| 03:09 ET | 600 | 6.988 |
| 03:12 ET | 100 | 6.988 |
| 03:14 ET | 3443 | 6.96 |
| 03:16 ET | 892 | 7.005 |
| 03:27 ET | 100 | 7.03 |
| 03:30 ET | 6331 | 6.99 |
| 03:36 ET | 1300 | 6.99 |
| 03:38 ET | 1200 | 6.99 |
| 03:39 ET | 524 | 6.99 |
| 03:41 ET | 5896 | 6.97 |
| 03:43 ET | 18112 | 6.93 |
| 03:45 ET | 2309 | 6.93 |
| 03:48 ET | 2300 | 6.92 |
| 03:50 ET | 200 | 6.93 |
| 03:52 ET | 700 | 6.925 |
| 03:54 ET | 1897 | 6.92 |
| 03:56 ET | 3810 | 6.91 |
| 03:57 ET | 9488 | 6.9125 |
| 03:59 ET | 9606 | 6.95 |
Yesterday
May 30, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. - CVRX, from 7:20PM ET on Thursday May 30, 2024 by Dow Jones
7:20PM ET on Thursday May 30, 2024 by Dow Jones
May 28, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. - CVRX, from 4:26PM ET on Tuesday May 28, 2024 by Dow Jones
4:26PM ET on Tuesday May 28, 2024 by Dow Jones
May 24, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. - CVRX, from 1:17PM ET on Friday May 24, 2024 by Dow Jones
1:17PM ET on Friday May 24, 2024 by Dow Jones
May 22, 2024
CVRx to Present at the William Blair 44th Annual Growth Stock Conference, from 8:30AM ET on Wednesday May 22, 2024 by Dow Jones
8:30AM ET on Wednesday May 22, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CVRx Inc | 150.1M | -2.8x | --- |
TELA Bio Inc | 136.3M | -3.3x | --- |
KORU Medical Systems Inc | 97.5M | -7.3x | --- |
Myomo Inc | 98.3M | -12.7x | --- |
Alpha Teknova Inc | 71.8M | -1.7x | --- |
Delcath Systems Inc | 195.9M | -2.7x | --- |
Company Information
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programed by a wireless clinician-controlled programmer that communicates with the IPG.
Contact Information
- Headquarters
- 9201 West Broadway Avenue, Suite 650MINNEAPOLIS, MN, United States 55445
- Phone
- 763-416-2850
- Fax
- 763-416-2841
Executives
- President, Chief Executive Officer, Director
- Kevin Hykes
- Chief Financial Officer
- Jared Oasheim
- Senior Vice President - US Sales
- Craig Palmer
- Senior Vice President - Global Clinical Affairs
- Jennifer Englund
- Senior Vice President - Patient Access, Reimbursement, and Health Care Economics
- Bonnie Handke
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $150.1M |
|---|---|
Revenue (TTM) | $42.1M |
Shares Outstanding | 21.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.48 |
Book Value | $3.64 |
P/E Ratio | -2.8x |
Price/Sales (TTM) | 3.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -126.34% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
